| Immunotherapy for cardiovascular disease E Lutgens, D Atzler, Y Döring, J Duchene, S Steffens, C Weber European heart journal 40 (48), 3937-3946, 2019 | 178 | 2019 |
| Targeting CD40-induced TRAF6 signaling in macrophages reduces atherosclerosis TTP Seijkens, CM van Tiel, PJH Kusters, D Atzler, O Soehnlein, ... Journal of the American College of Cardiology 71 (5), 527-542, 2018 | 178 | 2018 |
| Sex-based differences in cardiometabolic biomarkers J Lew, M Sanghavi, CR Ayers, DK McGuire, T Omland, D Atzler, MO Gore, ... Circulation 135 (6), 544-555, 2017 | 176 | 2017 |
| Homoarginine Levels Are Regulated by l-Arginine:Glycine Amidinotransferase and Affect Stroke Outcome: Results From Human and Murine Studies C Choe, D Atzler, PS Wild, AM Carter, RH Böger, F Ojeda, O Simova, ... Circulation 128 (13), 1451-1461, 2013 | 169 | 2013 |
| Symmetric dimethylarginine predicts all-cause mortality following ischemic stroke F Schulze, AM Carter, E Schwedhelm, R Ajjan, R Maas, RA von Holten, ... Atherosclerosis 208 (2), 518-523, 2010 | 158 | 2010 |
| Dimethylarginine dimethylaminohydrolase-1 is the critical enzyme for degrading the cardiovascular risk factor asymmetrical dimethylarginine X Hu, D Atzler, X Xu, P Zhang, H Guo, Z Lu, J Fassett, E Schwedhelm, ... Arteriosclerosis, thrombosis, and vascular biology 31 (7), 1540-1546, 2011 | 156 | 2011 |
| L-homoarginine and cardiovascular disease D Atzler, E Schwedhelm, C Choe Current Opinion in Clinical Nutrition & Metabolic Care 18 (1), 83-88, 2015 | 104 | 2015 |
| Homoarginine and cardiovascular outcome in the population-based Dallas Heart Study D Atzler, MO Gore, CR Ayers, C Choe, RH Böger, JA de Lemos, ... Arteriosclerosis, thrombosis, and vascular biology 34 (11), 2501-2507, 2014 | 100 | 2014 |
| Vascular endothelial-specific dimethylarginine dimethylaminohydrolase-1–deficient mice reveal that vascular endothelium plays an important role in removing asymmetric … X Hu, X Xu, G Zhu, D Atzler, M Kimoto, J Chen, E Schwedhelm, ... Circulation 120 (22), 2222-2229, 2009 | 98 | 2009 |
| Racial differences in cardiovascular biomarkers in the general population E Hackler III, J Lew, MO Gore, CR Ayers, D Atzler, A Khera, A Rohatgi, ... Journal of the American Heart Association 8 (18), e012729, 2019 | 92 | 2019 |
| Amino acids and their metabolism in atherosclerosis K Nitz, M Lacy, D Atzler Arteriosclerosis, thrombosis, and vascular biology 39 (3), 319-330, 2019 | 88 | 2019 |
| CXCL12 derived from endothelial cells promotes atherosclerosis to drive coronary artery disease Y Döring, EPC van der Vorst, J Duchene, Y Jansen, S Gencer, ... Circulation 139 (10), 1338-1340, 2019 | 87 | 2019 |
| Pathogenic cycle between the endogenous nitric oxide synthase inhibitor asymmetrical dimethylarginine and the leukocyte-derived hemoprotein myeloperoxidase EC von Leitner, A Klinke, D Atzler, JL Slocum, N Lund, JT Kielstein, ... Circulation 124 (24), 2735-2745, 2011 | 85 | 2011 |
| Symmetrical dimethylarginine predicts mortality in the general population: observations from the Dallas heart study MO Gore, N Lüneburg, E Schwedhelm, CR Ayers, M Anderssohn, ... Arteriosclerosis, thrombosis, and vascular biology 33 (11), 2682-2688, 2013 | 79 | 2013 |
| Dimethylarginine dimethylaminohydrolase overexpression ameliorates atherosclerosis in apolipoprotein E-deficient mice by lowering asymmetric dimethylarginine J Jacobi, R Maas, AJ Cardounel, M Arend, AJ Pope, N Cordasic, ... The American journal of pathology 176 (5), 2559-2570, 2010 | 75 | 2010 |
| Homoarginine—an independent marker of mortality in heart failure D Atzler, M Rosenberg, M Anderssohn, C Choe, M Lutz, C Zugck, ... International journal of cardiology 168 (5), 4907-4909, 2013 | 73 | 2013 |
| Serum reference intervals of homoarginine, ADMA, and SDMA in the study of health in Pomerania D Atzler, E Schwedhelm, M Nauck, T Ittermann, RH Böger, N Friedrich Clinical Chemistry and Laboratory Medicine (CCLM) 52 (12), 1835-1842, 2014 | 72 | 2014 |
| PD-L1 expression on nonclassical monocytes reveals their origin and immunoregulatory function M Bianchini, J Duchêne, D Santovito, MJ Schloss, M Evrard, H Winkels, ... Science immunology 4 (36), eaar3054, 2019 | 70 | 2019 |
| Cell-specific and divergent roles of the CD40L-CD40 axis in atherosclerotic vascular disease M Lacy, C Bürger, A Shami, M Ahmadsei, H Winkels, K Nitz, CM van Tiel, ... Nature communications 12 (1), 3754, 2021 | 68 | 2021 |
| Immunoinflammatory, thrombohaemostatic, and cardiovascular mechanisms in COVID-19 S Gencer, M Lacy, D Atzler, EPC van der Vorst, Y Doering, C Weber Thrombosis and haemostasis 120 (12), 1629-1641, 2020 | 68 | 2020 |